Female sexual dysfunction treatment
    3.
    发明授权
    Female sexual dysfunction treatment 失效
    女性性功能障碍治疗

    公开(公告)号:US06193992B1

    公开(公告)日:2001-02-27

    申请号:US09345009

    申请日:1999-07-02

    IPC分类号: A61F606

    CPC分类号: A61K31/485

    摘要: Sexual dysfunction in human females can be ameliorated, without substantial undesirable side effects, by apomorphine. Administration of apomorphine increases nerve stimulated clitoral intracavernosal blood flow and vaginal wall blood flow for enhanced clitoral erection and vaginal engorgement in a female. A plasma concentration of apomorphine of no more than about 5.5 nanograms per milliliter is preferably maintained.

    摘要翻译: 通过阿朴吗啡可以改善人类女性的性功能障碍,无明显不良副作用。 阿扑吗啡的施用增加神经刺激的阴蒂海绵体内血流量和阴道壁血流量,以增强女性的阴蒂勃起和阴道充盈。 优选维持阿扑吗啡的血药浓度不超过约5.5纳克每毫升。

    Amorphous paroxetine composition
    6.
    发明授权
    Amorphous paroxetine composition 失效
    无定形帕罗西汀组成

    公开(公告)号:US06503927B1

    公开(公告)日:2003-01-07

    申请号:US09428812

    申请日:1999-10-28

    IPC分类号: A61K31445

    摘要: A stable amorphous paroxetine hydrochloride composition suitable as a therapeutic agent is prepared employing an aqueous solvent medium containing an acidulant and polyvinylpyrrolidone and drying the resulting solid dispersion. The preferred compositions include amorphous paroxetine hydrochloride, polyvinylpyrrolidone and citric acid.

    摘要翻译: 使用含有酸性剂和聚乙烯吡咯烷酮的水性溶剂介质并干燥所得的固体分散体制备适合作为治疗剂的稳定的无定形帕罗西汀盐酸盐组合物。 优选的组合物包括无定形帕洛西汀盐酸盐,聚乙烯吡咯烷酮和柠檬酸。

    Amelioration of apomorphine adverse effects
    7.
    发明授权
    Amelioration of apomorphine adverse effects 失效
    改善阿扑吗啡的不良反应

    公开(公告)号:US5994363A

    公开(公告)日:1999-11-30

    申请号:US138982

    申请日:1998-08-24

    CPC分类号: A61K31/473

    摘要: Symptoms of Parkinson's disease and psychogenic male erectile dysfunction (MED) can be ameliorated through the use of apomorphine. The adverse side effects of apomorphine administration, such as nausea, vomiting, yawning, and cardiovascular effects, can be significantly reduced by a dose escalating method of acclimatization. An initial dose of apomorphine is administered to the patient, and subsequently increased over a period of time until a final apomorphine dose in excess of a desired therapeutic dose has been received by the patient. Thereafter a therapeutic dose of apomorphine, less than the final apomorphine dose, is administered to the patient with attendant reduced side effects.

    摘要翻译: 可以通过使用阿扑吗啡来改善帕金森病和精神性男性勃起功能障碍(MED)的症状。 阿扑吗啡给药的不良副作用,如恶心,呕吐,打呵欠和心血管作用,可以通过剂量不断升高的驯化方法显着降低。 将阿扑吗啡的初始剂量施用于患者,随后在一段时间内增加,直到患者已经接受超过所需治疗剂量的最终阿扑吗啡剂量。 此后,给患者施用小于最终阿扑吗啡剂量的阿扑吗啡的治疗剂量,伴随着降低的副作用。